Myocardial Fibrosis and Cardiomyopathy Risk: A Genetic Link in the MESA
Mahsima Shabani(Houston Methodist), Naveen L. Pereira(Mayo Clinic)
Cited by 11
Related Papers
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials
|European Heart Journal|2021|150
International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention
|JACC: Cardiovascular Interventions|2024|93
Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association
|Circulation Genomic and Precision Medicine|2019|60
Post‐discharge arrhythmic risk stratification of patients with acute myocarditis and life‐threatening ventricular tachyarrhythmias
|European Journal of Heart Failure|2021|40